Continued use of Atorvostatin in sepsis

Category Primary study
Registry of TrialsANZCTR
Year 2005
INTERVENTION: Atorvostatin as continuation of statin therapy for a 28 day study period ( or until discharge form hospital) CONDITION: Sepsis / infection in patients taking statin therapy PRIMARY OUTCOME: Incidence of severe sepsis SECONDARY OUTCOME: 28 Day mortality Biological markers of inflammation , lipid profile , oxidative stress. INCLUSION CRITERIA: All patients with sepsis syndrome who are on statin therapy at the time of admisison to hospital are eligable for inclusion.
Epistemonikos ID: 728ee9d2a4b9aa380d4ff42ee0b76fcf0761c055
First added on: Aug 21, 2024